December 2021

The Covid-19 pandemic has highlighted more clearly than ever the need for security and traceability at every step of the drug supply chain.


In the next issue of Pharma Technology Focus we look at how digitising the pharma supply chain – and utilising blockchain technology – can ensure medicines travel from manufacturer to patient with greater visibility and security, and reduce the risk of counterfeit drugs entering supplies.


Also, for patients that are struggling to get hold of vital medical because of supply chain issues or are left without legally approved medications due to political rulings, the dark web can be a tempting – if risky – solution.


To find out why illegal online pharmacies have become a final resort, we talk to some of those impacted by drug shortages, and the companies that are having to compete with illegal trade.

EDITORIAL

Editor | Eloise McLennan

Writers | Abi Millar, Darcy Jimenez, Kezia Parkins
Magazine Designer | Maria Gimenez

Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Filipe Costa, Martina Labaiova, Dimeji Akinkuolie, Will Ingham​​​​​​​
Lead Designer | John Hammond 

Publisher | Susanne Hauner
Digital Publishing Director | Duncan West

Advertising

Sales Manager | Nimai Amin

+44 (0) 207 936 6453

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.